Your browser doesn't support javascript.
loading
Estimating mortality and disability in Peru before the COVID-19 pandemic: a systematic analysis from the Global Burden of the Disease Study 2019.
Rios-Blancas, Maria Jesus; Pando-Robles, Victoria; Razo, Christian; Carcamo, Cesar P; Mendoza, Walter; Pacheco-Barrios, Kevin; Miranda, J Jaime; Lansingh, Van Charles; Demie, Takele Gezahegn; Saha, Manika; Okonji, Osaretin Christabel; Yigit, Arzu; Cahuana-Hurtado, Lucero; Chacón-Uscamaita, Pamela R; Bernabe, Eduardo; Culquichicon, Carlos; Chirinos-Caceres, Jesus Lorenzo; Cárdenas, Rosario; Alcalde-Rabanal, Jacqueline Elizabeth; Barrera, Francisco J; Quintanilla, Beatriz Paulina Ayala; Shorofi, Seyed Afshin; Wickramasinghe, Nuwan Darshana; Ferreira, Nuno; Almidani, Louay; Gupta, Vivek Kumar; Karimi, Hanie; Alayu, Daniel Shewaye; Benziger, Catherine P; Fukumoto, Takeshi; Mostafavi, Ebrahim; Redwan, Elrashdy Moustafa Mohamed; Gebrehiwot, Mesfin; Khatab, Khaled; Koyanagi, Ai; Krapp, Fiorella; Lee, Seung; Noori, Maryam; Qattea, Ibrahim; Rosenthal, Victor Daniel; Sakshaug, Joseph W; Wagaye, Birhanu; Zare, Iman; Ortega-Altamirano, Doris V; Murillo-Zamora, Efrén; Vervoort, Dominique; Silva, Diego Augusto Santos; Oulhaj, Abderrahim; Herrera-Serna, Brenda Yuliana; Mehra, Rahul.
Afiliação
  • Rios-Blancas MJ; School of Public Health of Mexico, National Institute of Public Health, Cuernavaca, Mexico.
  • Pando-Robles V; Carlos Slim Foundation, Mexico City, Mexico.
  • Razo C; Infectious Disease Research Center, National Institute of Public Health, Cuernavaca, Mexico.
  • Carcamo CP; Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, United States.
  • Mendoza W; School of Public Health and Administration, Universidad Peruana Cayetano Heredia, Lima, Peru.
  • Pacheco-Barrios K; Peru Country Office, United Nations Population Fund (UNFPA), Lima, Peru.
  • Miranda JJ; Spaulding Rehabilitation Hospital, Harvard University, Boston, MA, United States.
  • Lansingh VC; Universidad San Ignacio de Loyola (University of Saint Ignatius of Loyola), Lima, Peru.
  • Demie TG; CRONICAS Centre of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia (Cayetano Heredia Peruvian University), Lima, Peru.
  • Saha M; Department of Medicine, Universidad Peruana Cayetano Heredia (Cayetano Heredia Peruvian University), Lima, Peru.
  • Okonji OC; HelpMeSee, New York, NY, United States.
  • Yigit A; Mexican Institute of Ophthalmology, Queretaro, Mexico.
  • Cahuana-Hurtado L; School of Public Health, St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
  • Chacón-Uscamaita PR; Department of Humanities and Social Sciences, Deakin University, Melbourne, VIC, Australia.
  • Bernabe E; Department of Human-Centred Computing, Monash University, Melbourne, VIC, Australia.
  • Culquichicon C; School of Pharmacy, University of the Western Cape, Cape Town, South Africa.
  • Chirinos-Caceres JL; Department of Health Management, Süleyman Demirel Üniversitesi (Süleyman Demirel University), Isparta, Türkiye.
  • Cárdenas R; School of Public Health and Administration, Universidad Peruana Cayetano Heredia, Lima, Peru.
  • Alcalde-Rabanal JE; Emerge, Emerging Diseases and Climate Change Research Unit, School of Public Health and Administration, Universidad Peruana Cayetano Heredia, Lima, Peru.
  • Barrera FJ; Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, London, United Kingdom.
  • Quintanilla BPA; Universidad Privada Norbert Wiener, Centro de Investigación Epidemiológica en Salud Global, Lima, Peru.
  • Shorofi SA; School of Public Health and Administration, Universidad Peruana Cayetano Heredia, Lima, Peru.
  • Wickramasinghe ND; Department of Health Care, Metropolitan Autonomous University, Mexico City, Mexico.
  • Ferreira N; Center for Health Systems Research, National Institute of Public Health, Cuernavaca, Mexico.
  • Almidani L; Department of Epidemiology, Harvard University, Boston, MA, United States.
  • Gupta VK; The Judith Lumley Centre, La Trobe University, Melbourne, VIC, Australia.
  • Karimi H; San Martin de Porres University, Lima, Peru.
  • Alayu DS; Medical-Surgical Nursing, Mazandaran University of Medical Sciences, Sari, Iran.
  • Benziger CP; College of Nursing and Health Sciences, Flinders University, Adelaide, SA, Australia.
  • Fukumoto T; Department of Community Medicine, Rajarata University of Sri Lanka, Anuradhapura, Sri Lanka.
  • Mostafavi E; Department of Social Sciences, University of Nicosia, Nicosia, Cyprus.
  • Redwan EMM; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
  • Gebrehiwot M; Doheny Image Reading and Research Lab (DIRRL) - Doheny Eye Institute, University of California, Los Angeles, Los Angeles, CA, United States.
  • Khatab K; Faculty of Medicine Health and Human Sciences, Macquarie University, Sydney, NSW, Australia.
  • Koyanagi A; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Krapp F; Department of Epidemiology and Biostatistics, University of Gondar, Gondar, Ethiopia.
  • Lee S; Heart and Vascular Center, Essentia Health, Duluth, MN, United States.
  • Noori M; Department of Dermatology, Kobe University, Kobe, Japan.
  • Qattea I; Department of Medicine, Stanford University, Palo Alto, CA, United States.
  • Rosenthal VD; Stanford Cardiovascular Institute, Stanford University, Palo Alto, CA, United States.
  • Sakshaug JW; Department Biological Sciences, King Abdulaziz University, Jeddah, Egypt.
  • Wagaye B; Department of Protein Research, Research and Academic Institution, Alexandria, Egypt.
  • Zare I; Department of Environmental Health, Wollo University, Dessie, Ethiopia.
  • Ortega-Altamirano DV; Health and Wellbeing, Sheffield Hallam University, Sheffield, United Kingdom.
  • Murillo-Zamora E; Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Sant Boi de Llobregat, Spain.
  • Vervoort D; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain.
  • Silva DAS; Instituto de Medicina Tropical Alexander von Humboldt (Alexander von Humboldt Institute for Tropical Medicine), Cayetano Heredia University, Lima, Peru.
  • Oulhaj A; Doctoral School of Biomedical Sciences, Katholieke Universiteit Leuven, Leuven, Belgium.
  • Herrera-Serna BY; Department of Precision Medicine, Sungkyunkwan University, Suwon-si, Republic of Korea.
  • Mehra R; Student Research Committee, Iran University of Medical Sciences, Tehran, Iran.
Front Public Health ; 11: 1189861, 2023.
Article em En | MEDLINE | ID: mdl-37427272
Background: Estimating and analyzing trends and patterns of health loss are essential to promote efficient resource allocation and improve Peru's healthcare system performance. Methods: Using estimates from the Global Burden of Disease (GBD), Injuries, and Risk Factors Study (2019), we assessed mortality and disability in Peru from 1990 to 2019. We report demographic and epidemiologic trends in terms of population, life expectancy at birth (LE), mortality, incidence, prevalence, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) caused by the major diseases and risk factors in Peru. Finally, we compared Peru with 16 countries in the Latin American (LA) region. Results: The Peruvian population reached 33.9 million inhabitants (49.9% women) in 2019. From 1990 to 2019, LE at birth increased from 69.2 (95% uncertainty interval 67.8-70.3) to 80.3 (77.2-83.2) years. This increase was driven by the decline in under-5 mortality (-80.7%) and mortality from infectious diseases in older age groups (+60 years old). The number of DALYs in 1990 was 9.2 million (8.5-10.1) and reached 7.5 million (6.1-9.0) in 2019. The proportion of DALYs due to non-communicable diseases (NCDs) increased from 38.2% in 1990 to 67.9% in 2019. The all-ages and age-standardized DALYs rates and YLLs rates decreased, but YLDs rates remained constant. In 2019, the leading causes of DALYs were neonatal disorders, lower respiratory infections (LRIs), ischemic heart disease, road injuries, and low back pain. The leading risk factors associated with DALYs in 2019 were undernutrition, high body mass index, high fasting plasma glucose, and air pollution. Before the COVID-19 pandemic, Peru experienced one of the highest LRIs-DALYs rates in the LA region. Conclusion: In the last three decades, Peru experienced significant improvements in LE and child survival and an increase in the burden of NCDs and associated disability. The Peruvian healthcare system must be redesigned to respond to this epidemiological transition. The new design should aim to reduce premature deaths and maintain healthy longevity, focusing on effective coverage and treatment of NCDs and reducing and managing the related disability.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Respiratórias / Doenças não Transmissíveis / COVID-19 Tipo de estudo: Risk_factors_studies Limite: Aged / Child, preschool / Female / Humans / Infant / Male / Middle aged / Newborn País/Região como assunto: America do sul / Peru Idioma: En Revista: Front Public Health Ano de publicação: 2023 Tipo de documento: Article País de afiliação: México

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Respiratórias / Doenças não Transmissíveis / COVID-19 Tipo de estudo: Risk_factors_studies Limite: Aged / Child, preschool / Female / Humans / Infant / Male / Middle aged / Newborn País/Região como assunto: America do sul / Peru Idioma: En Revista: Front Public Health Ano de publicação: 2023 Tipo de documento: Article País de afiliação: México